LiquidCaffeine.com – FDA Warning Letter, Mar 1, 2018

The FDA issued a Warning Letter to Liquidcaffeine.com following a January 2018 product purchase and a March 2018 review of its label and website. The FDA determined that the Liquid Caffeine product is adulterated under section 402(f)(1)(A)(i) of the Federal Food, Drug, and Cosmetic Act, as it presents a significant or unreasonable risk of illness or injury under recommended use conditions. This risk is attributed to several factors: the product's label directs use by "pumps" (83 mg caffeine per pump), but no pump is included. Instead, a 1 fl. oz. measuring cup is provided, which contains approximately 500 mg of caffeine (six "one-pump" servings). Consumers may mistakenly perceive this cup as a single serving due to the lack of clear conversion and the absence of a pump. The 16-ounce package contains about 8 grams of caffeine, representing multiple toxic doses and potentially lethal amounts. The letter highlights the dangers of caffeine consumption exceeding 500 mg, including increased half-life and toxic effects like chest pain and irregular heartbeat. The firm was also cautioned about a two-gallon product that could pose similar, amplified risks. Liquidcaffeine.com must promptly correct these violations and respond in writing within fifteen working days, detailing specific corrective actions, including those for products already in the marketplace, to avoid legal action such as seizure or injunction.